Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nicholas Manguso"'
Autor:
Nicholas Manguso, Andrew Eugene Hendifar, Jun Gong, Veronica Placencio-Hickok, Katelyn M. Atkins, Haesoo Kim, Joseph Chao, Sungjin Kim, Michelle Guan, Miguel Burch, Samuel J. Klempner, Mitchell Kamrava, Alexandra Gangi, Jar-Yee Liu
Publikováno v:
Journal of Clinical Oncology. 38:316-316
316 Background: We investigated predictors for chemotherapy (CTX) and prognostic variables in a large metastatic esophageal cancer (mEC) patient data set. Methods: We interrogated the National Cancer Database between 2004-2015 and included patients (
Autor:
Jun Gong, Shirley C Paski, Brian Cox, Alexandra Gangi, Andrew Eugene Hendifar, Nicholas Manguso, Jessica S. Crystal
Publikováno v:
Journal of Clinical Oncology. 38:613-613
613 Background: Demographic and socioeconomic disparities have been shown to effect cancer specific outcomes in numerous malignancies but the effect in midgut neuroendocrine tumors (mNETs) is unknown. We sought to investigate whether these factors ar
Autor:
Jessica S. Crystal, R. Tuli, Mitchell Kamrava, Andrew Eugene Hendifar, Jun Gong, Nicholas Manguso, Humair S Quadri, Jaewon Lee, Alexandra Gangi, Katelyn M. Atkins, Brian Cox
Publikováno v:
Journal of Clinical Oncology. 38:682-682
682 Background: Lymph node (LN) metastases affect overall survival (OS) in pancreatic cancer (PC). However, a LN sampling threshold does not exist. We examined the impact of nodal sampling on overall survival (OS). Methods: Patients with Stage I-III
Publikováno v:
Journal of Clinical Oncology. 37:446-446
446 Background: Surgical management of metastatic midgut neuroendocrine tumors (NET) remains controversial. Resection of primary tumor only without liver resection is advocated only in select patients, frequently for palliation. Additionally, no stan
Autor:
James Mirocha, Nicholas N. Nissen, Nicholas Manguso, Attiya Harit, Farin Amersi, Andrew Eugene Hendifar
Publikováno v:
Journal of Clinical Oncology. 35:e15688-e15688
e15688 Background: Management of liver metastasis in patients with small bowel neuroendocrine tumors (SBNET) remains unclear. Complete surgical resection improves long term survival however factors that influence overall prognosis are not clear. Meth